dexmedetomidine has been researched along with Idiopathic Pulmonary Fibrosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, S; Huang, W; Lai, X; Lin, Y; Pu, L; Wang, Z; Zeng, Q | 1 |
1 other study(ies) available for dexmedetomidine and Idiopathic Pulmonary Fibrosis
| Article | Year |
|---|---|
Dexmedetomidine alleviates pulmonary fibrosis through the ADORA2B-Mediated MAPK signaling pathway.
Topics: Animals; Dexmedetomidine; Idiopathic Pulmonary Fibrosis; MAP Kinase Signaling System; Mice; Receptor, Adenosine A2B; Signal Transduction | 2023 |